XTX Topco Ltd Reduces Stake in Amedisys, Inc. (NASDAQ:AMED)

Key Points

• XTX Topco Ltd has reduced its stake in Amedisys, Inc. by 58.6% during the first quarter, leaving them with 8,983 shares valued at $832,000.
• Amedisys' recent earnings report showed a 5.2% revenue increase year-over-year, with an EPS of $1.54, exceeding analysts' expectations of $1.39.
• Wall Street analysts have mixed opinions on Amedisys, with Royal Bank Of Canada maintaining an "outperform" rating and setting a price target of $100, while Wall Street Zen downgraded it from "strong-buy" to "buy."

XTX Topco Ltd cut its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 58.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,983 shares of the health services provider's stock after selling 12,714 shares during the period. XTX Topco Ltd's holdings in Amedisys were worth $832,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Hexagon Capital Partners LLC raised its position in Amedisys by 108.1% in the 1st quarter. Hexagon Capital Partners LLC now owns 310 shares of the health services provider's stock valued at $29,000 after purchasing an additional 161 shares during the last quarter. MassMutual Private Wealth & Trust FSB increased its stake in Amedisys by 56.1% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 334 shares of the health services provider's stock worth $31,000 after buying an additional 120 shares during the period. Fifth Third Bancorp boosted its stake in Amedisys by 68.1% during the 1st quarter. Fifth Third Bancorp now owns 348 shares of the health services provider's stock valued at $32,000 after acquiring an additional 141 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Amedisys by 100.0% during the first quarter. UMB Bank n.a. now owns 386 shares of the health services provider's stock worth $36,000 after purchasing an additional 193 shares during the period. Finally, Johnson Financial Group Inc. acquired a new stake in Amedisys in the fourth quarter worth $55,000. Institutional investors own 94.36% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Wall Street Zen downgraded shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research report on Saturday, May 24th. Royal Bank Of Canada reiterated an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a research note on Wednesday, April 16th.

Amedisys Trading Up 1.6%

NASDAQ AMED traded up $1.60 during mid-day trading on Thursday, reaching $100.89. 2,937,860 shares of the stock were exchanged, compared to its average volume of 394,795. Amedisys, Inc. has a one year low of $82.15 and a one year high of $100.99. The stock has a market cap of $3.32 billion, a P/E ratio of 39.26, a P/E/G ratio of 1.34 and a beta of 0.89. The stock has a 50 day simple moving average of $97.08 and a 200-day simple moving average of $94.31. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.36 and a quick ratio of 1.36.

Amedisys (NASDAQ:AMED - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The health services provider reported $1.54 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.15. Amedisys had a net margin of 3.56% and a return on equity of 12.91%. The firm had revenue of $621.86 million during the quarter, compared to analyst estimates of $614.61 million. During the same period in the previous year, the business earned $0.98 EPS. The business's revenue for the quarter was up 5.2% on a year-over-year basis. On average, analysts anticipate that Amedisys, Inc. will post 4.4 EPS for the current year.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.